关注
Simon Legood
Simon Legood
在 pasteur.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
RND efflux pumps in Gram-negative bacteria; regulation, structure and role in antibiotic resistance
AL Colclough, I Alav, EE Whittle, HL Pugh, EM Darby, SW Legood, ...
Future microbiology 15 (2), 143-157, 2020
1112020
Identification of binding residues between periplasmic adapter protein (PAP) and RND efflux pumps explains PAP-pump promiscuity and roles in antimicrobial resistance
HE McNeil, I Alav, RC Torres, AE Rossiter, E Laycock, S Legood, I Kaur, ...
PLoS pathogens 15 (12), e1008101, 2019
412019
Flow cytometric analysis of efflux by dye accumulation
EE Whittle, SW Legood, I Alav, P Dulyayangkul, TW Overton, JMA Blair
Frontiers in Microbiology 10, 2319, 2019
242019
Mode of action of lipoprotein modification enzymes—Novel antibacterial targets
S Legood, IG Boneca, N Buddelmeijer
Molecular Microbiology 115 (3), 356-365, 2021
122021
A Defect in Lipoprotein Modification by Lgt Leads to Abnormal Morphology and Cell Death in Escherichia coli That Is Independent of Major Lipoprotein Lpp
S Legood, D Seng, IG Boneca, N Buddelmeijer
Journal of Bacteriology 204 (9), e00164-22, 2022
62022
Microwave decontamination of eyelid warming devices for the treatment of meibomian gland dysfunction
P Bilkhu, JS Wolffsohn, A Hilton, G Matthews, S Legood, L Riley
Contact Lens and Anterior Eye 39 (4), 293-297, 2016
22016
Effects of therapeutic and sanitisation heating on the microbiology of warm compress treatment
P Bilkhu, J Wolffsohn, S Naroo, A Hilton, S Legood
Contact Lens and Anterior Eye 41, S14, 2018
12018
H-NS is a bacterial transposon capture protein
C Cooper, S Legood, RL Wheat, D Forrest, P Sharma, JRJ Haycocks, ...
Nature Communications 15 (1), 7137, 2024
2024
The lipoprotein modification enzyme Lgt as a potential target for novel antibiotics
S Legood
Université Paris Cité, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–9